Loading
Latest filing published 30 May 2025 for Checkpoint Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William Garrett Gray appears in our data through filings on Checkpoint Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 26 filings, for trades running from 30 January 2018 to 30 May 2025.
On the market, this insider has only sold: 15 sales, €1.7M in total. The rest of the record consists of 10 share grants. So far in 2025, the count stands at no purchases and 2 sales.
The latest filing, published on 30 May 2025, reports a transaction in Checkpoint Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations